Table 1.
Sample Characteristics
| No Chronic Pain (N=36) | Chronic Pain (N=20) | p | |
|---|---|---|---|
| Age* | 47.92 (9.97) | 50.40 (8.12) | .35 |
| Sex (% Male)* | 72.2 | 80.0 | .52 |
| Race* | |||
| % African American | 58.3 | 40.0 | .10 |
| % Caucasian | 33.3 | 60.0 | |
| % Other | 8.3 | 0 | |
| Education* | |||
| % Some HS | 11.1 | 10.0 | .13 |
| % HS degree or GED | 72.2 | 50.0 | |
| % Some College | 16.7 | 30.0 | |
| % College Grad | 0 | 10.0 | |
| Methadone Treatment (%)* | 52.8 | 35.0 | .20 |
| Positive Urine (%)** | 40.13 (37.32) | 36.39 (39.05) | .73 |
| Opioid Craving (EMA mean score)** | 1.32 (.48) | 1.31 (.43) | .91 |
| CES-D Total Score* | 13.00 (8.56) | 12.75 (6.21) | .91 |
| BPI Pain Severity* | 1.82 (1.98) | 4.64 (2.16) | < .001 |
| BPI Pain Interference* | 2.04 (2.54) | 5.09 (2.81) | < .001 |
Note. HS = High School.
*
at enrollment
**
during the study